NVIDIA CUDA Technology Dramatically Advances the Pace of Scientifi...(ghts reserved. NVIDIA the NVIDIA logoGeF...)

    (i)  Based on a consistent and reproducible SETI@home workload.
         Time-to-compute is measured and lower time is better.  NVIDIA(R)
         GeForce(R) GTX 280-based system processes workload on the NVIDIA GPU
         and is based on an NVIDIA nForce(R) 780i SLI(TM)-based motherboard,
         NVIDIA GTX 280 GPU, Intel Core i7 965 CPU, 2GB DDR2 DRAM and
         processes the workload in 391 seconds.  "Fastest consumer multicore
         CPU-based system" processes the entire workload on CPU and is based
         on an ATI Radeon HD4870 GPU, Intel x58-based motherboard, Intel Core
         i7 965, 3GB DDR3 DRAM and processes the workload in 670 seconds.
         "Average dual core CPU-based system" processes the entire workload on
         CPU and is based on an ATI Radeon HD4870 GPU, AMD Phenom 9950 CPU
         (Dual Core 2.66GHz) 2GB DDR2 DRAM and processes the workload in 3,777
         seconds

    (ii) Based on a consistent and reproducible SETI@home workload.
         Time-to-compute is measured and lower time is better.  NVIDIA(R)
         GeForce(R) GTX 280-based system processes workload on the NVIDIA GPU
         and is based on an NVIDIA nForce(R) 780i SLI(TM)-based motherboard,
         NVIDIA GTX 280 GPU, Intel Core i7 965 CPU, 2GB DDR2 DRAM and
         processes the workload in 391 seconds.  "Fastest consumer multicore
         CPU-based system" processes the entire workload on CPU and is based
         on an ATI Radeon HD4870 GPU, Intel x58-based motherboard, Intel Core
         i7 965, 3GB DDR3 DRAM and processes the workload in 670 seconds.

'/>"/>
SOURCE  NVIDIA
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 
Related biology technology :

1. Probiotic Delivery Technology Awarded Third International Patent
2. Bolder BioTechnology Receives $1.9 Million NIH Grant to Continue Development of Long-Acting Growth Hormone Product
3. Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology
4. Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement
5. Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts
6. Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
7. Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops
8. Align Technology Receives Expanded Regulatory Approval in Japan
9. Genome Technology Names 2008 Tomorrows PIs
10. BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization
11. J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology